Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ankur Dhingra Insider Profile
4 Followers
Ankur Dhingra, CFO at CareDx, holds 354.96K shares in Summit Therapeutics (Ticker: SMMT), holds 38.15K shares in CareDx (Ticker: CDNA). Most recently, Ankur Dhingra Bought ― shares of Summit Therapeutics on Mar 27, 2024 for an estimated value of 375.00K.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+53.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 08, 2023 - Mar 08, 2024
Return:+189.40%
The most profitable trade made by Ankur Dhingra
Ankur Dhingra's Trading History
CareDx
Mar 28, 2022
CFO
Uninformative Sell
47.53K
$370.78K
Summit Therapeutics
Mar 27, 2024
CFO
Informative Buy
375.00K
$1.56M
List of latest transactions for each holding click on a transaction to see Ankur Dhingra's performance on stock
You May Also Like
Ankur Dhingra insider profile FAQ
What is the percentage of profitable transactions made by Ankur Dhingra?
The percentage of profitable transactions made by Ankur Dhingra is 80%.
What is the average return per transaction made by Ankur Dhingra?
The average return per transaction made by Ankur Dhingra is 53.90%.
What stocks does Ankur Dhingra hold?
Ankur Dhingra holds: CDNA, SMMT stocks.
What was Ankur Dhingra’s latest transaction?
Ankur Dhingra latest transaction was an Informative Buy of $375.00K.
What was Ankur Dhingra's most profitable transaction?
Ankur Dhingra’s most profitable transaction was an Informative Buy of SMMT stock on March 8, 2023. The return on the trade was 189.40%.
What is Ankur Dhingra's role in CareDx?
Ankur Dhingra's role in CareDx is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.